As for the preferred second-line agent, 80% of responders chose rituximab while only 10% chose cyclophosphamide in a clinical ... bench have not been paralleled by advancement in clinical practice, ...

Its main goal is to be an aid for security professionals to test their skills and tools in a legal environment, help web developers better understand the processes of securing web applications and to ...